biotech news today glp-1 Baseline, Roche, Intellia, Eli Lilly: Readout Newsletter Science's 2023 Breakthrough: GLP-1 Agonists

The goal wasnt just results but results that stick, for good

And at the maximum studied dose of 12 mg, average weight loss hit 24.2% at 48 weeks

These observations prompted new clinical studies designed specifically to measure GLP-1's effect on weight loss rather than glucose control

I tried another GLP-1 telehealth service first, the medication arrived and that was basically the last I heard from them

Diabetes health coaching - Some manufacturers offer complementary support services alongside savings programs

At least a 5% weight reduction was achieved in 85% of those who received SMG, compared with only 26% in the placebo group